These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8052609)

  • 1. Detection of exocyclic 1,N2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans.
    Nath RG; Chung FL
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7491-5. PubMed ID: 8052609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues.
    Nath RG; Ocando JE; Chung FL
    Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 32P-postlabeling method for simultaneous detection and quantification of exocyclic etheno and propano adducts in DNA.
    Nath RG; Chen HJ; Nishikawa A; Young-Sciame R; Chung FL
    Carcinogenesis; 1994 May; 15(5):979-84. PubMed ID: 8200104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue.
    Nath RG; Ocando JE; Guttenplan JB; Chung FL
    Cancer Res; 1998 Feb; 58(4):581-4. PubMed ID: 9485001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of 1,N2-propano-2'-deoxyguanosine adducts derived from acrolein and crotonaldehyde in human placenta and leukocytes by isotope dilution nanoflow LC nanospray ionization tandem mass spectrometry.
    Chen HJ; Lin WP
    Anal Chem; 2009 Dec; 81(23):9812-8. PubMed ID: 19899782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cyclic 1,N2-propanodeoxyguanosine adducts in DNA of rats treated with N-nitrosopyrrolidine and mice treated with crotonaldehyde.
    Chung FL; Young R; Hecht SS
    Carcinogenesis; 1989 Jul; 10(7):1291-7. PubMed ID: 2736720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A solid-phase extraction/high-performance liquid chromatography-based (32)P-postlabeling method for detection of cyclic 1,N(2)-propanodeoxyguanosine adducts derived from enals.
    Pan J; Davis W; Trushin N; Amin S; Nath RG; Salem N; Chung FL
    Anal Biochem; 2006 Jan; 348(1):15-23. PubMed ID: 16289438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.
    Maccubbin AE; Lee L; Struck RF; Gurtoo HL
    Chem Biol Interact; 1992 Sep; 84(1):21-35. PubMed ID: 1394614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a 32P-postlabelling method for the detection of 1,N2-propanodeoxyguanosine adducts of crotonaldehyde in vivo.
    Schuler BD; Eder E
    Arch Toxicol; 2000 Sep; 74(7):404-14. PubMed ID: 11043496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangement of the (6S,8R,11S) and (6R,8S,11R) exocyclic 1,N2-deoxyguanosine adducts of trans-4-hydroxynonenal to N2-deoxyguanosine cyclic hemiacetal adducts when placed complementary to cytosine in duplex DNA.
    Huang H; Wang H; Qi N; Kozekova A; Rizzo CJ; Stone MP
    J Am Chem Soc; 2008 Aug; 130(33):10898-906. PubMed ID: 18661996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of cyclic 1,N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde.
    Chung FL; Young R; Hecht SS
    Cancer Res; 1984 Mar; 44(3):990-5. PubMed ID: 6318992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 1,N2-propanodeoxyguanosine adducts as endogenous DNA lesions in rodents and humans.
    Chung FL; Zhang L; Ocando JE; Nath RG
    IARC Sci Publ; 1999; (150):45-54. PubMed ID: 10626207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and 32P-postlabeling/high-performance liquid chromatography separation of diastereomeric 1,N2-(1,3-propano)-2'-deoxyguanosine 3'-phosphate adducts formed from 4-hydroxy-2-nonenal.
    Yi P; Zhan D; Samokyszyn VM; Doerge DR; Fu PP
    Chem Res Toxicol; 1997 Nov; 10(11):1259-65. PubMed ID: 9403180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources.
    Chung FL; Nath RG; Ocando J; Nishikawa A; Zhang L
    Cancer Res; 2000 Mar; 60(6):1507-11. PubMed ID: 10749113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of 1,N2-propanodeoxyguanosine adducts of 2-hexenal in organs of Fischer 344 rats by a 32P-post-labeling technique.
    Schuler D; Eder E
    Carcinogenesis; 1999 Jul; 20(7):1345-50. PubMed ID: 10383910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal after gavage of trans-4-hydroxy-2-nonenal or induction of lipid peroxidation with carbon tetrachloride in F344 rats.
    Wacker M; Wanek P; Eder E
    Chem Biol Interact; 2001 Sep; 137(3):269-83. PubMed ID: 11566294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of cyclic deoxyguanosine adducts in Chinese hamster ovary cells by acrolein and crotonaldehyde.
    Foiles PG; Akerkar SA; Miglietta LM; Chung FL
    Carcinogenesis; 1990 Nov; 11(11):2059-61. PubMed ID: 2225341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach.
    Eder E; Schuler D; Budiawan
    IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous formation and significance of 1,N2-propanodeoxyguanosine adducts.
    Chung FL; Nath RG; Nagao M; Nishikawa A; Zhou GD; Randerath K
    Mutat Res; 1999 Mar; 424(1-2):71-81. PubMed ID: 10064851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of acrolein-derived 1,N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers.
    Zhang S; Balbo S; Wang M; Hecht SS
    Chem Res Toxicol; 2011 Jan; 24(1):119-24. PubMed ID: 21090699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.